Fujifilm Snaps Up Cellular Dynamics To Grow Stem Cell Business
Jeff Engel Cellular Dynamics International, an up-and-coming player in the stem cell field and one of Wisconsin’s more promising biotech companies, is being acquired by Fujifilm for $307 million in...
View ArticleThe Story Behind Cellular Dynamics’ Sale to Fujifilm
Jeff Engel Last week, Cellular Dynamics International CEO Bob Palay described the $307 million acquisition of his company by Fujifilm as a union of two businesses that “share a common strategic vision...
View ArticleStanford Spins Out Immunotherapy Work Funded By CIRM’s Millions
A new cancer immunotherapy company has spun out of Stanford University with backing from a quartet of venture investors and a big hand from the taxpayers of California. The Palo Alto, CA-based firm,...
View ArticleSan Antonio’s Incell, Belgian Investor Hatch JV for Bio Products
San Antonio — [Corrected 6/10/16, 11:10 a.m. See Below.] Incell, a contract manufacturer for the biotech industry for two decades, is starting a new business with a Belgian investor. Its purpose: to...
View ArticleMetis Foundation, Targeting Military Researchers, Plans Fund Raise
San Antonio — [Corrected 1:20 p.m. See below.] A San Antonio nonprofit that aims to help medical researchers earn grants is beginning to raise money for a program that it says may be able to provide...
View ArticleCalifornia Agency Awards Humacyte $9.9M for Blood Vessel Technology
Humacyte hopes its regenerative medicine approach to blood vessels can offer a better and longer-lasting alternative to synthetic implants used to replace blocked veins. Now it has $9.9 million more...
View ArticleWith $6M Investment, Histogen Aims to Grow Hair Business in China
Histogen, a San Diego-based regenerative medicine company with technology for growing skin cells and related products, said it has raised $6 million from an affiliate of Huapont Life Sciences, a...
View ArticleCellular Dynamics Says It Will Split Into Two Business Units
Cellular Dynamics International, a Madison, WI-based manufacturer of human cells, said on Thursday that it has divided the company into two business units, one for therapeutics and the other for life...
View ArticleOwl Manor’s Regenerative Medicine Veterinary Tech Lands $1.2M Round
Regenerative medicine techniques offer ways to tap into the body’s own healing abilities to treat injuries. Owl Manor Veterinary says its technology offers a better alternative to other biological...
View ArticleProgenerative Plans Bone, Business Growth From Revived Acelity Tech
San Antonio — After any acquisition, jobs can be lost, programs are cut, and the business changes its focus. That was true in the years after Kinetic Concepts was acquired by a private equity group...
View ArticleBioBridge Plans to Grow $7.8M into Large-Scale Stem Cell Production
San Antonio — A San Antonio life sciences nonprofit is working with three other organizations to learn how to produce larger volumes of stem cells, and has received $7.8 million from a military-based...
View ArticleTour of Texas: Twyla, Firefly, Factom, DocSynk, Disruptors, & More
Let’s get caught up with the latest innovation news from Xconomy Texas. Austin: —Factom, a startup that uses blockchain technology to secure and verify data such as public records and business...
View ArticleSan Antonio’s Fountainhead Raising Money to Back Up Biomed Incubator
A San Antonio venture capital firm that recently created a biotech and medical device incubator is raising additional funding and may make investments in the coming months, according to managing...
View ArticleTenaya Spins Out of Gladstone With $50M to Fight Heart Disease
The human body can’t repair the heart damage that leads to heart failure. But new biopharmaceutical company Tenaya Therapeutics aims to find a way by turning research from the nonprofit Gladstone...
View ArticleBlueRock Raises $225M To Repair Heart Damage With Stem Cells
A new stem cell therapeutics company, BlueRock Therapeutics, has launched with $225 million in funding from international healthcare giant Bayer and Versant Ventures. Using work from Nobel Prize...
View ArticleOrganovo Discloses First Preclinical Data on Human Liver “Patch”
After taking the first steps toward the development of living human liver tissue “patches” for therapeutic use, San Diego-based Organovo (NASDAQ: ONVO) is laying out its pre-clinical data for the...
View ArticleTexas Roundup: “1st & Future,” “Pink Tank” Pitch Contests, & More
As we approach Santa’s annual visit—are your milk and cookies ready?—let’s get caught up with the latest innovation news from Xconomy Texas: —The National Football League has teamed up with the Texas...
View ArticleWatching for NIH Innovation in 2017—and Drug Pricing, Trade Deals
With the inauguration of Donald Trump as president on January 20th, the editors asked some of our Xconomists to offer their thoughts on “How could the incoming administration significantly affect your...
View ArticleCytori Buys San Antonio-based Azaya’s Drug Delivery Tech for Stock
San Antonio — Cytori Therapeutics, a San Diego, CA-based developer of drugs that use patients’ own fat tissues to make cellular therapies, is buying the assets of San Antonio-based Azaya Therapeutics...
View ArticleWith $294M, Kamen Hopes to Bring Regenerative Medicine “Up to Scale”
Dean Kamen is, among other things, an inventor, entrepreneur, and leader in the technology and nonprofit fields. The products he and his company, Manchester, NH-based DEKA Research & Development,...
View Article